Insider Transactions in Q1 2025 at Avanos Medical, Inc. (AVNS)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2025
|
Michael Greiner Interim CEO |
BUY
Grant, award, or other acquisition
|
Direct |
34,316
+13.27%
|
-
|
|
Mar 07
2025
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,877
+18.79%
|
-
|
|
Mar 07
2025
|
John Joseph Hurley Principal Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,961
+14.35%
|
-
|
|
Mar 07
2025
|
Mojirade James SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
19,201
+17.87%
|
-
|
|
Mar 07
2025
|
Sigfrido Delgado SVP, Operations |
BUY
Grant, award, or other acquisition
|
Direct |
10,213
+26.85%
|
-
|
|
Mar 06
2025
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,064
-3.76%
|
$90,960
$15.3 P/Share
|
|
Mar 06
2025
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,000
-7.86%
|
$105,000
$15.25 P/Share
|
|
Mar 06
2025
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
13,597
-3.39%
|
$203,955
$15.3 P/Share
|
|
Mar 06
2025
|
Joseph Fralin Woody |
SELL
Payment of exercise price or tax liability
|
Direct |
32,076
-3.75%
|
$481,140
$15.3 P/Share
|
|
Mar 06
2025
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
353
-1.76%
|
$5,295
$15.3 P/Share
|
|
Mar 06
2025
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,631
-3.19%
|
$69,465
$15.3 P/Share
|
|
Mar 04
2025
|
Joseph Fralin Woody |
SELL
Payment of exercise price or tax liability
|
Direct |
18,351
-2.05%
|
$275,265
$15.13 P/Share
|
|
Mar 04
2025
|
Joseph Fralin Woody |
BUY
Exercise of conversion of derivative security
|
Direct |
32,158
+6.63%
|
-
|
|
Mar 04
2025
|
Mojirade James SVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
4,704
-3.05%
|
$70,560
$15.13 P/Share
|
|
Mar 04
2025
|
Mojirade James SVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
8,039
+9.31%
|
-
|
|
Mar 04
2025
|
Michael Greiner Interim CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
10,690
-2.53%
|
$160,350
$15.13 P/Share
|
|
Mar 04
2025
|
Michael Greiner Interim CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
12,149
+5.37%
|
-
|
|
Mar 04
2025
|
John Joseph Hurley Principal Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
71
-0.35%
|
$1,065
$15.13 P/Share
|
|
Mar 04
2025
|
John Joseph Hurley Principal Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
107
+1.04%
|
-
|
|
Mar 04
2025
|
Kerr Holbrook SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,346
-1.83%
|
$50,190
$15.13 P/Share
|
|
Mar 04
2025
|
Kerr Holbrook SVP, Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,145
+5.27%
|
-
|
|
Jan 02
2025
|
Indrani Lall Franchini Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,003
+41.64%
|
-
|
|
Jan 02
2025
|
Lisa Egbuonu Davis Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,003
+31.74%
|
-
|
|
Jan 02
2025
|
Gary Blackford Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,003
+14.36%
|
-
|
|
Jan 02
2025
|
Julie Ann Shimer Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,003
+16.2%
|
-
|
|
Jan 02
2025
|
Patrick J Oleary Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,003
+15.26%
|
-
|